nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP1A2—Carmustine—malignant glioma	0.501	1	CbGbCtD
Moclobemide—Apathy—Temozolomide—malignant glioma	0.00607	0.0434	CcSEcCtD
Moclobemide—Flat affect—Temozolomide—malignant glioma	0.00602	0.043	CcSEcCtD
Moclobemide—Bezafibrate—PPARG—malignant glioma	0.00501	0.634	CrCbGaD
Moclobemide—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00458	0.0328	CcSEcCtD
Moclobemide—Hot flush—Temozolomide—malignant glioma	0.00336	0.024	CcSEcCtD
Moclobemide—Menopausal symptoms—Temozolomide—malignant glioma	0.00334	0.0238	CcSEcCtD
Moclobemide—Procainamide—BCHE—malignant glioma	0.00289	0.366	CrCbGaD
Moclobemide—Dry skin—Temozolomide—malignant glioma	0.00288	0.0206	CcSEcCtD
Moclobemide—Abdominal distension—Temozolomide—malignant glioma	0.00274	0.0196	CcSEcCtD
Moclobemide—Dysuria—Temozolomide—malignant glioma	0.00254	0.0182	CcSEcCtD
Moclobemide—Stomatitis—Carmustine—malignant glioma	0.00245	0.0175	CcSEcCtD
Moclobemide—Stomatitis—Temozolomide—malignant glioma	0.00236	0.0169	CcSEcCtD
Moclobemide—Hallucination—Carmustine—malignant glioma	0.00224	0.016	CcSEcCtD
Moclobemide—Visual impairment—Carmustine—malignant glioma	0.00217	0.0155	CcSEcCtD
Moclobemide—Hallucination—Temozolomide—malignant glioma	0.00217	0.0155	CcSEcCtD
Moclobemide—Visual impairment—Temozolomide—malignant glioma	0.0021	0.015	CcSEcCtD
Moclobemide—Flushing—Carmustine—malignant glioma	0.00209	0.0149	CcSEcCtD
Moclobemide—Tinnitus—Temozolomide—malignant glioma	0.00203	0.0145	CcSEcCtD
Moclobemide—Flushing—Temozolomide—malignant glioma	0.00202	0.0144	CcSEcCtD
Moclobemide—Dysgeusia—Temozolomide—malignant glioma	0.00186	0.0133	CcSEcCtD
Moclobemide—Vision blurred—Carmustine—malignant glioma	0.00185	0.0132	CcSEcCtD
Moclobemide—Tremor—Carmustine—malignant glioma	0.00184	0.0131	CcSEcCtD
Moclobemide—Agitation—Carmustine—malignant glioma	0.0018	0.0129	CcSEcCtD
Moclobemide—Vision blurred—Temozolomide—malignant glioma	0.00179	0.0128	CcSEcCtD
Moclobemide—Tremor—Temozolomide—malignant glioma	0.00178	0.0127	CcSEcCtD
Moclobemide—Ill-defined disorder—Temozolomide—malignant glioma	0.00176	0.0126	CcSEcCtD
Moclobemide—Agitation—Temozolomide—malignant glioma	0.00174	0.0124	CcSEcCtD
Moclobemide—Malaise—Temozolomide—malignant glioma	0.00171	0.0122	CcSEcCtD
Moclobemide—Hypertension—Carmustine—malignant glioma	0.00169	0.0121	CcSEcCtD
Moclobemide—Palpitations—Temozolomide—malignant glioma	0.00167	0.012	CcSEcCtD
Moclobemide—Chest pain—Carmustine—malignant glioma	0.00167	0.0119	CcSEcCtD
Moclobemide—Myalgia—Carmustine—malignant glioma	0.00167	0.0119	CcSEcCtD
Moclobemide—Anxiety—Carmustine—malignant glioma	0.00166	0.0119	CcSEcCtD
Moclobemide—Hypertension—Temozolomide—malignant glioma	0.00164	0.0117	CcSEcCtD
Moclobemide—Confusional state—Carmustine—malignant glioma	0.00161	0.0115	CcSEcCtD
Moclobemide—Myalgia—Temozolomide—malignant glioma	0.00161	0.0115	CcSEcCtD
Moclobemide—Anxiety—Temozolomide—malignant glioma	0.00161	0.0115	CcSEcCtD
Moclobemide—Discomfort—Temozolomide—malignant glioma	0.00159	0.0114	CcSEcCtD
Moclobemide—Dry mouth—Temozolomide—malignant glioma	0.00158	0.0113	CcSEcCtD
Moclobemide—Tachycardia—Carmustine—malignant glioma	0.00156	0.0112	CcSEcCtD
Moclobemide—Confusional state—Temozolomide—malignant glioma	0.00156	0.0111	CcSEcCtD
Moclobemide—Hypotension—Carmustine—malignant glioma	0.0015	0.0107	CcSEcCtD
Moclobemide—Hyperhidrosis—Temozolomide—malignant glioma	0.0015	0.0107	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00146	0.0104	CcSEcCtD
Moclobemide—Insomnia—Carmustine—malignant glioma	0.00145	0.0103	CcSEcCtD
Moclobemide—Paraesthesia—Carmustine—malignant glioma	0.00144	0.0103	CcSEcCtD
Moclobemide—Dyspnoea—Carmustine—malignant glioma	0.00143	0.0102	CcSEcCtD
Moclobemide—Somnolence—Carmustine—malignant glioma	0.00142	0.0102	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00141	0.0101	CcSEcCtD
Moclobemide—Insomnia—Temozolomide—malignant glioma	0.0014	0.01	CcSEcCtD
Moclobemide—Decreased appetite—Carmustine—malignant glioma	0.00139	0.00994	CcSEcCtD
Moclobemide—Paraesthesia—Temozolomide—malignant glioma	0.00139	0.00992	CcSEcCtD
Moclobemide—Dyspnoea—Temozolomide—malignant glioma	0.00138	0.00985	CcSEcCtD
Moclobemide—Somnolence—Temozolomide—malignant glioma	0.00138	0.00983	CcSEcCtD
Moclobemide—Constipation—Carmustine—malignant glioma	0.00137	0.00978	CcSEcCtD
Moclobemide—Dyspepsia—Temozolomide—malignant glioma	0.00136	0.00973	CcSEcCtD
Moclobemide—Decreased appetite—Temozolomide—malignant glioma	0.00134	0.00961	CcSEcCtD
Moclobemide—Fatigue—Temozolomide—malignant glioma	0.00133	0.00953	CcSEcCtD
Moclobemide—Constipation—Temozolomide—malignant glioma	0.00132	0.00945	CcSEcCtD
Moclobemide—Feeling abnormal—Carmustine—malignant glioma	0.00132	0.00942	CcSEcCtD
Moclobemide—Gastrointestinal pain—Carmustine—malignant glioma	0.00131	0.00935	CcSEcCtD
Moclobemide—Feeling abnormal—Temozolomide—malignant glioma	0.00127	0.00911	CcSEcCtD
Moclobemide—Abdominal pain—Carmustine—malignant glioma	0.00127	0.00904	CcSEcCtD
Moclobemide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00126	0.00904	CcSEcCtD
Moclobemide—Urticaria—Temozolomide—malignant glioma	0.00123	0.00878	CcSEcCtD
Moclobemide—Abdominal pain—Temozolomide—malignant glioma	0.00122	0.00874	CcSEcCtD
Moclobemide—Asthenia—Carmustine—malignant glioma	0.00115	0.00821	CcSEcCtD
Moclobemide—Asthenia—Temozolomide—malignant glioma	0.00111	0.00793	CcSEcCtD
Moclobemide—Diarrhoea—Carmustine—malignant glioma	0.0011	0.00783	CcSEcCtD
Moclobemide—Pruritus—Temozolomide—malignant glioma	0.00109	0.00782	CcSEcCtD
Moclobemide—Dizziness—Carmustine—malignant glioma	0.00106	0.00756	CcSEcCtD
Moclobemide—Diarrhoea—Temozolomide—malignant glioma	0.00106	0.00756	CcSEcCtD
Moclobemide—Dizziness—Temozolomide—malignant glioma	0.00102	0.00731	CcSEcCtD
Moclobemide—Vomiting—Carmustine—malignant glioma	0.00102	0.00727	CcSEcCtD
Moclobemide—Rash—Carmustine—malignant glioma	0.00101	0.00721	CcSEcCtD
Moclobemide—Dermatitis—Carmustine—malignant glioma	0.00101	0.0072	CcSEcCtD
Moclobemide—Headache—Carmustine—malignant glioma	0.001	0.00716	CcSEcCtD
Moclobemide—Vomiting—Temozolomide—malignant glioma	0.000984	0.00703	CcSEcCtD
Moclobemide—Rash—Temozolomide—malignant glioma	0.000975	0.00697	CcSEcCtD
Moclobemide—Dermatitis—Temozolomide—malignant glioma	0.000974	0.00696	CcSEcCtD
Moclobemide—Headache—Temozolomide—malignant glioma	0.000969	0.00692	CcSEcCtD
Moclobemide—Nausea—Carmustine—malignant glioma	0.000951	0.00679	CcSEcCtD
Moclobemide—Nausea—Temozolomide—malignant glioma	0.000919	0.00656	CcSEcCtD
Moclobemide—MAOB—Metabolism—COX8A—malignant glioma	0.000619	0.00176	CbGpPWpGaD
Moclobemide—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	0.000609	0.00173	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.0006	0.00171	CbGpPWpGaD
Moclobemide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000595	0.00169	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000594	0.00169	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000591	0.00168	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000586	0.00167	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—BCHE—malignant glioma	0.000571	0.00163	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP2C18—malignant glioma	0.000565	0.00161	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000561	0.0016	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP2C18—malignant glioma	0.000557	0.00159	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—SLC6A3—malignant glioma	0.000537	0.00153	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ASMT—malignant glioma	0.000527	0.0015	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.00052	0.00148	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000515	0.00147	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000513	0.00146	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000508	0.00145	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	0.000508	0.00145	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	0.000501	0.00143	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—BCAN—malignant glioma	0.000495	0.00141	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—GSTT1—malignant glioma	0.000457	0.0013	CbGpPWpGaD
Moclobemide—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000441	0.00126	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	0.00044	0.00125	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	0.000434	0.00124	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—PTGS1—malignant glioma	0.000428	0.00122	CbGpPWpGaD
Moclobemide—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	0.000422	0.0012	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.00042	0.0012	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000417	0.00119	CbGpPWpGaD
Moclobemide—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000402	0.00114	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—IDH2—malignant glioma	0.000399	0.00114	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000394	0.00112	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000391	0.00111	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—COX8A—malignant glioma	0.000389	0.00111	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000383	0.00109	CbGpPWpGaD
Moclobemide—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	0.000381	0.00108	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000381	0.00108	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.00038	0.00108	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP2B6—malignant glioma	0.000375	0.00107	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000367	0.00105	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000364	0.00104	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTT1—malignant glioma	0.000356	0.00101	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000349	0.000993	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000348	0.000991	CbGpPWpGaD
Moclobemide—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000344	0.000978	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—IDH1—malignant glioma	0.000343	0.000977	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000342	0.000973	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.00034	0.000969	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000334	0.00095	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SPHK1—malignant glioma	0.000332	0.000946	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ASMT—malignant glioma	0.000331	0.000941	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP2C18—malignant glioma	0.000325	0.000926	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—RTEL1—malignant glioma	0.00032	0.000912	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000319	0.000908	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000318	0.000905	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.000317	0.000902	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000312	0.00089	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—BCAN—malignant glioma	0.000311	0.000885	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000295	0.000841	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000295	0.000839	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000292	0.000832	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—BRAF—malignant glioma	0.000292	0.00083	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000291	0.00083	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000289	0.000824	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000289	0.000822	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000287	0.000818	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000285	0.000811	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000266	0.000758	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTT1—malignant glioma	0.000263	0.000749	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.00026	0.000741	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.00026	0.000741	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000253	0.000721	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—IDH2—malignant glioma	0.00025	0.000713	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—RTEL1—malignant glioma	0.00025	0.000711	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000248	0.000706	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000248	0.000706	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTP1—malignant glioma	0.000247	0.000703	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS1—malignant glioma	0.000247	0.000702	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000246	0.0007	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—MDM2—malignant glioma	0.000244	0.000695	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	0.000243	0.000693	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—RAF1—malignant glioma	0.000243	0.000693	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP2B6—malignant glioma	0.000236	0.00067	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—BCHE—malignant glioma	0.000229	0.000653	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000229	0.000652	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SLC5A5—malignant glioma	0.000226	0.000645	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000222	0.000631	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—IDH1—malignant glioma	0.000215	0.000613	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000209	0.000594	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SPHK1—malignant glioma	0.000208	0.000593	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP2C18—malignant glioma	0.000204	0.000581	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000202	0.000575	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—COX8A—malignant glioma	0.000184	0.000524	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTP1—malignant glioma	0.000182	0.000519	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000178	0.000508	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CAT—malignant glioma	0.000178	0.000505	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000173	0.000491	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—COX8A—malignant glioma	0.000169	0.000482	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—COX8A—malignant glioma	0.000168	0.000478	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NCOR1—malignant glioma	0.000168	0.000477	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTT1—malignant glioma	0.000165	0.00047	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000164	0.000468	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ASMT—malignant glioma	0.000156	0.000445	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS1—malignant glioma	0.000155	0.000441	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000153	0.000435	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00015	0.000427	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BCAN—malignant glioma	0.000147	0.000419	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ASMT—malignant glioma	0.000144	0.00041	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—BCHE—malignant glioma	0.000144	0.00041	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—COX8A—malignant glioma	0.000143	0.000408	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ASMT—malignant glioma	0.000143	0.000406	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC5A5—malignant glioma	0.000142	0.000405	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000139	0.000397	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CAV1—malignant glioma	0.000137	0.000389	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BCAN—malignant glioma	0.000135	0.000385	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BCAN—malignant glioma	0.000134	0.000382	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000128	0.000365	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CG—malignant glioma	0.000124	0.000354	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ASMT—malignant glioma	0.000122	0.000347	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PPARG—malignant glioma	0.00012	0.000342	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000119	0.000339	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—IDH2—malignant glioma	0.000119	0.000338	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BCAN—malignant glioma	0.000115	0.000326	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTP1—malignant glioma	0.000114	0.000326	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000112	0.000318	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.000111	0.000317	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAT—malignant glioma	0.000111	0.000317	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CD—malignant glioma	0.000109	0.000312	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—IDH2—malignant glioma	0.000109	0.00031	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—IDH2—malignant glioma	0.000108	0.000308	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NCOR1—malignant glioma	0.000105	0.000299	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000103	0.000292	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—IDH1—malignant glioma	0.000102	0.00029	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000102	0.00029	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000102	0.000289	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SPHK1—malignant glioma	9.87e-05	0.000281	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2C18—malignant glioma	9.67e-05	0.000275	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CB—malignant glioma	9.54e-05	0.000272	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—malignant glioma	9.45e-05	0.000269	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—IDH1—malignant glioma	9.38e-05	0.000267	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—IDH1—malignant glioma	9.3e-05	0.000265	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—IDH2—malignant glioma	9.24e-05	0.000263	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.11e-05	0.000259	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SPHK1—malignant glioma	9.07e-05	0.000258	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SPHK1—malignant glioma	9e-05	0.000256	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2C18—malignant glioma	8.89e-05	0.000253	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2C18—malignant glioma	8.81e-05	0.000251	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.71e-05	0.000248	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2B6—malignant glioma	8.69e-05	0.000247	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAV1—malignant glioma	8.58e-05	0.000244	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.31e-05	0.000237	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.3e-05	0.000236	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTEN—malignant glioma	8.24e-05	0.000235	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.01e-05	0.000228	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—IDH1—malignant glioma	7.94e-05	0.000226	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTT1—malignant glioma	7.82e-05	0.000223	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CG—malignant glioma	7.81e-05	0.000222	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SPHK1—malignant glioma	7.69e-05	0.000219	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.57e-05	0.000215	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARG—malignant glioma	7.54e-05	0.000215	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2C18—malignant glioma	7.53e-05	0.000214	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS1—malignant glioma	7.32e-05	0.000209	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.31e-05	0.000208	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.3e-05	0.000208	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTT1—malignant glioma	7.19e-05	0.000205	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTT1—malignant glioma	7.13e-05	0.000203	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.1e-05	0.000202	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CD—malignant glioma	6.87e-05	0.000195	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BCHE—malignant glioma	6.81e-05	0.000194	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS1—malignant glioma	6.74e-05	0.000192	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.73e-05	0.000191	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS1—malignant glioma	6.68e-05	0.00019	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.65e-05	0.000189	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.47e-05	0.000184	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.36e-05	0.000181	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.3e-05	0.000179	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BCHE—malignant glioma	6.26e-05	0.000178	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.24e-05	0.000178	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BCHE—malignant glioma	6.21e-05	0.000177	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.19e-05	0.000176	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.13e-05	0.000175	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTT1—malignant glioma	6.09e-05	0.000173	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CB—malignant glioma	5.98e-05	0.00017	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—malignant glioma	5.93e-05	0.000169	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—malignant glioma	5.81e-05	0.000166	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.8e-05	0.000165	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.75e-05	0.000164	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS1—malignant glioma	5.71e-05	0.000162	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.69e-05	0.000162	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.5e-05	0.000156	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTP1—malignant glioma	5.42e-05	0.000154	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BCHE—malignant glioma	5.31e-05	0.000151	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAT—malignant glioma	5.27e-05	0.00015	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC5A5—malignant glioma	5.24e-05	0.000149	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTEN—malignant glioma	5.17e-05	0.000147	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.01e-05	0.000143	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTP1—malignant glioma	4.98e-05	0.000142	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOR1—malignant glioma	4.98e-05	0.000142	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.96e-05	0.000141	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTP1—malignant glioma	4.94e-05	0.000141	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.91e-05	0.00014	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAT—malignant glioma	4.85e-05	0.000138	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAT—malignant glioma	4.81e-05	0.000137	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—malignant glioma	4.75e-05	0.000135	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOR1—malignant glioma	4.58e-05	0.00013	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOR1—malignant glioma	4.54e-05	0.000129	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.28e-05	0.000122	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTP1—malignant glioma	4.22e-05	0.00012	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAT—malignant glioma	4.11e-05	0.000117	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAV1—malignant glioma	4.06e-05	0.000116	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOR1—malignant glioma	3.88e-05	0.00011	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.88e-05	0.00011	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAV1—malignant glioma	3.73e-05	0.000106	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAV1—malignant glioma	3.7e-05	0.000105	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.7e-05	0.000105	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—malignant glioma	3.65e-05	0.000104	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARG—malignant glioma	3.57e-05	0.000102	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.54e-05	0.000101	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.4e-05	9.68e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.37e-05	9.6e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARG—malignant glioma	3.28e-05	9.34e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARG—malignant glioma	3.25e-05	9.26e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.25e-05	9.25e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAV1—malignant glioma	3.16e-05	9e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.02e-05	8.6e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.99e-05	8.51e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—malignant glioma	2.98e-05	8.49e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.96e-05	8.44e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.88e-05	8.2e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.83e-05	8.07e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—malignant glioma	2.81e-05	7.99e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARG—malignant glioma	2.78e-05	7.92e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.61e-05	7.42e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.58e-05	7.35e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—malignant glioma	2.58e-05	7.35e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—malignant glioma	2.56e-05	7.29e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.53e-05	7.21e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTEN—malignant glioma	2.45e-05	6.97e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTEN—malignant glioma	2.25e-05	6.41e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTEN—malignant glioma	2.23e-05	6.35e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.21e-05	6.28e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—malignant glioma	2.19e-05	6.23e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTEN—malignant glioma	1.91e-05	5.43e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.73e-05	4.92e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.59e-05	4.52e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.57e-05	4.48e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—malignant glioma	1.41e-05	4.02e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.35e-05	3.83e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—malignant glioma	1.3e-05	3.69e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—malignant glioma	1.29e-05	3.66e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—malignant glioma	1.1e-05	3.13e-05	CbGpPWpGaD
